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Introduction
Elective total hip and knee arthroplasty (THA and 
TKA) are becoming increasingly frequent procedures 
due to population ageing and obesity, especially in the 
United States of America and Europe, where the number 
of such procedures is expected to double in the next 10 
years1. An important cost element in these procedures 
is blood management, which accounts for 5.27% of 
overall costs in THA2 today and increased by 80% for 
TKA from 1991 to 20093.
Blood transfusion requirements depend directly on 
surgical technique, procedure duration, haemostatic 
accuracy and the patient's characteristics4. Since 
non-functional recovery from total joint arthroplasty 
(TJA) is influenced by blood loss, the transfusion 
strategy adopted is a crucial factor in restoring the 
patient's physiological status5,6. In the last decades 
a variety of approaches have been developed to 
minimise the effect of blood loss on surgical outcome. 
For example, minimally invasive surgery has a lesser 
impact on muscles and soft tissues, thus providing for 
faster recovery of limb function, and, compared with 
classical techniques, it is associated with significantly 
less blood loss5,6. 
Other approaches intended to reduce the use of 
allogeneic blood and to address the related issues, in 
terms of blood availability and risks of infection, include 
pre-operative autologous blood donation (PABD) and 
post-operative cell salvage (PCS). Despite the enormous 
impact that these techniques can have on outcome after 
TJA, their real effectiveness is still unclear. The specific 
literature is limited and the results are often discrepant. 
Background. Blood loss during total joint arthroplasty strongly influences the time to recover 
after surgery and the quality of the recovery. Blood conservation strategies such as pre-operative 
autologous blood donation and post-operative cell salvage are intended to avoid allogeneic blood 
transfusions and their associated risks. Although widely investigated, the real effectiveness of these 
alternative transfusion practices remains controversial.
Materials and methods. The surgery reports of 600 patients undergoing total joint arthroplasty 
(312 hip and 288 knee replacements) were retrospectively reviewed to assess transfusion needs and 
related blood management at our institute. Evaluation parameters included post-operative blood 
loss, haemoglobin concentration measured at different time points, ASA score, and blood transfusion 
strategies.
Results. Autologous blood donation increased the odds of receiving a red blood cell transfusion. 
Reinfusion by a cell salvage system of post-operative shed blood was found to limit adverse effects in 
cases of severe post-operative blood loss. The peri-operative net decrease in haemoglobin concentration 
was higher in patients who had predeposited autologous blood than in those who had not.
Discussion. The strengths of this study are the high number of cases and the standardised 
procedures, all operations having been performed by a single orthopaedic surgeon and a single 
anaesthesiologist. Our data suggest that a pre-operative autologous donation programme may often 
be useless, if not harmful. Conversely, the use of a cell salvage system may be effective in reducing 
the impact of blood transfusion on a patient's physiological status. Basal haemoglobin concentration 
emerged as a useful indicator of transfusion probability in total joint replacement procedures.
Keywords: total hip arthroplasty, total knee arthroplasty, pre-operative autologous blood donation, 
post-operative blood cell salvage system, blood management.
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Some studies report that PABD can significantly reduce 
allogeneic blood usage7,8, while others have criticised it 
because of the large number of wasted autologous blood 
units and the risk of orthopaedic-induced anemia9-11. With 
regard to PCS, some studies have shown that it is ineffective 
in restoring basal haemoglobin concentration12,13, while 
others have found the opposite14,15.
Against this background, the aim of the present study 
was to review the blood management and transfusion 
practices currently applied to TJA at our Institute in order 
to better understand what is useful and what is not in 
patients' care and cost reduction. Specifically, we wanted 
to assess the real effectiveness of the PABD programme 
in place at our Institute and to test the predictive potential 
of haemoglobin concentration, patient's age and gender 
in guiding blood requirements associated with TJA. To 
do this, we collected and retrospectively analysed the 
data from 600 surgery reports of patients who underwent 
TKA or THA at our Institute.
Materials and methods
Data collection
We reviewed the surgery reports of 600 patients 
who underwent TJA at the Prosthetic Surgery Centre 
of the IRCCS Galeazzi Orthopedic Institute between 
January 2010 and June 2011. A standardised procedure 
was ensured to the extent that all operations were 
performed by a single orthopaedic surgeon and a single 
anaesthesiologist. Parameters evaluated included: 
patient's age and gender; type of surgery (TKA or THA); 
post-operative blood loss (shed blood volume); PCS use; 
haemoglobin concentration measured at three time points 
(baseline, post-operative, discharge); American Society 
of Anesthesiologists (ASA) score; co-morbidities; and 
transfusion strategy (PABD, allogeneic or neither). 
The basal haemoglobin concentration was measured 
about 30 days before surgery, the post-operative 
haemoglobin concentration was measured within 6 hours 
after the operation, after PCS reinfusion if administered, 
and the last haemoglobin value was taken on the day of 
discharge (between 1 and 33 days after the operation). In 
addition, the haemoglobin concentration was measured 
immediately before blood administration in patients who 
received a transfusion. 
Minimally invasive surgical technique 
TKA was performed via a minimally invasive 
approach which involves a shorter skin incision and 
a mini-mid-vastus access to the joint and the use of 
extramedullary guides. No tourniquets were applied. The 
average operating time for TKA was 45 minutes. THA 
was performed using either a modified posterolateral 
approach passing through the gemellus inferior and the 
quadratus femoris muscles or an anterolateral Rottinger 
approach to minimise damage to muscle tissue, followed 
by implantation of neck-preserving short stems. The 
average operating time for THA was 40 minutes.
Anaesthesiology and transfusion
Hypotensive spinal anaesthesia was performed by 
the same anaesthesiologist on all patients. Immediately 
after surgery, the patients were transferred to the 
recovery room and monitored under the care of a 
blood management team. A drain was placed in each 
patient. A transfusion team leader was appointed to take 
decisions about blood reinfusion and transfusion. PCS 
blood was re-infused when the drainage volume was 
more than 300 mL within 6 hours after surgery, and 
allogeneic or autologous blood was transfused when 
the haemoglobin concentration fell to 8 g/dL or if signs 
and symptoms of anaemia developed. PCS blood was 
reinfused after blood washing (AutologTM, Medtronic, 
Minneapolis, MN, USA) and supernatant separation 
(Dry WashTM, Euroset, Medolla, MO, Italy) in order 
to obtain a high concentration of red blood cells in the 
re-infused PCS blood.
Patients were advised to participate in a PABD 
programme between 15 and 21 days before surgery. 
Each patient donated 1 blood unit and only ASA class 
I or II patients, with a basal haemoglobin concentration 
>12.5 g/dL were allowed to donate blood. The 
PABD programme did not include erythropoietin 
administration. No post-operative thromboembolic 
events occurred.
Statistical analysis
Data are presented as means ± standard deviation. 
Student's t-test was used to compare the groups for 
quantitative variables and the χ2 test for qualitative 
variables. A P value <0.05 was considered statistically 
significant. Receiver operating characteristic (ROC) 
analysis was applied to assess the predictive potential of 
basal haemoglobin concentration on transfusion needs.
Results
Selection and demographic characteristics of the 
patients
A total of 600 surgery reports (288 TKA and 312 
THA) were retrospectively reviewed and the data were 
manually entered into a computer database. The series 
was composed of 214 (37.5%) males (81 TKA and 
133 THA) and 386 (62.5%) females (207 TKA and 
179 THA); the mean age of the patients in the TKA 
group was 70.5±9.1 years, while that of the THA group 
was 65.3±12.4 years. Co-morbidities were present 
in 418 patients; hypertension was the most common 
(78.5%). The mean basal haemoglobin concentration 
was 13.9±1.3 g/dL and was higher in males. A total 
of 182 patients participated in the PABD programme. 
Co-morbidities, most often hypertension, were present 
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in 93 of these patients. Allogeneic units of blood were 
reserved for 374 patients: one unit was reserved for 353 
patients and more than one unit (2 to 4) was reserved for 
21 patients. The mean basal haemoglobin concentration 
in this latter group was 12.1±1.6 g/dL, which was 
significantly lower than that in the overall sample 
(P <0.001). These patients were all transfused after 
surgery and were, therefore, excluded from further 
analysis, since their need for transfusion appeared 
obvious. No units of blood (either allogeneic or 
autologous) were reserved for 44 patients. These 
patients' mean basal haemoglobin concentration 
(14.1±1.7 g/dL) was similar to that of the overall 
series. This category was mixed: some had no units 
of blood reserved because of the low risk of requiring 
transfusion, others because of blood supply shortage or 
PABD was not applicable or because religious beliefs 
(Jehovah's Witness) precluded blood transfusion. 
Given this marked variability, this category was 
excluded from further analysis. Patients with a basal 
haemoglobin concentration <12.5 g/dL (n =68) and 
ASA III patients (n =13) were deemed not suitable for 
PABD and so were also excluded from further analysis.
PCS was applied to all the patients in the final 
analysis (n =461). These patients were sorted into two 
groups according to transfusion strategy: PCS patients 
(with 1 allogeneic unit of blood reserved; n =279) and 
PABD+PCS patients (n =182). Table I summarizes 
the demographic and baseline characteristics of the 
patients in each group. Overall, the PABD+PCS group 
was younger, healthier (lower ASA class and fewer 
co-morbidities) and had a higher basal haemoglobin 
concentration than the PCS group, but the time spent in 
hospital and the male:female ratio were similar for the 
two groups. THA was slightly more frequent than TKA 
in both groups. 
Blood loss
The amount of shed blood refers to drainage volume. 
An additional index of blood loss is the difference in 
haemoglobin concentrations measured at baseline, 
after surgery and at discharge or at transfusion. The 
blood loss was higher in the TKA patients (P <0.001), 
whereas the post-operative decrease in haemoglobin 
concentration (post-operative haemoglobin minus 
basal haemoglobin concentration) was significantly 
greater in the THA patients (P <0.001), even if, after 
blood transfusion, the decrease in haemoglobin 
concentration at discharge was similar for both 
groups. The same results were seen for both groups 
(PABD+PCS and PCS), even if the differences in blood 
loss and in post-operative decrease in haemoglobin 
concentration between the TKA and THA patients in 
the PABD+PCS group were not statistically significant. 
Table I - Characteristics of the patients at baseline.
Overall PABD+PCS PCS
N. of patients (%) 461 (100) 182 (39.5) 279 (60.5)
Age (years) 66.9±10.7 62.5±9.4*** 69.7±10.5***
Male sex (%) 38.6 37.7 39.4
Basal Hb (g/dL) 14.2±1.1 14.5±1.0*** 14.0±1.1***
N. of days in hospital 3.9±2.4 4.1±2.8 3.7±2.1
Blood loss in TKA (mL) 511±240£££ 491±224 523±249£££
Blood loss in THA (mL) 436±184£££ 442±205 431±167£££
Decrease in Hb concentration after TKA (g/dL) –2.2±0.9§§§ –2.9±0.9*** –1.8±0.8***;§§§
Decrease in Hb concentration after THA (g/dL) –2.6±1.0§§§ –3.1±0.9*** –2.2±0.9***;§§§
Co-morbidities
Hypertension - n. (%) 255 (55.3) 89 (48.9)* 166 (59.5)*
Diabetes - n. (%) 36 (7.8) 8 (4.4)* 28(10.0)*
Coronary artery disease - n. (%) 45 (9.8) 1 (0.0)*** 44 (15.8)***
Kidney disease - n. (%) 35 (7.6) 11 (6.0) 24 (8.6)
ASA Class
I - n. (%) 84 (18.2) 61 (33.5)*** 23 (8.2)***
II - n. (%) 377 (81.8) 121 (66.5)*** 256 (91.8)***
Procedure 
Unilateral TKA - n. 218 82 136
Unilateral THA - n. 243 100 143
Legend ***P <0.001, between PABD+PCS and PCS only patients (same row); §§§ and £££p <0.001 between TKA and THA (same column). 
 Plus-minus values are means ± SD. PABD: pre-operative blood donation; PCS: post-operative cell salvage; TKA: total knee arthroplasty; THA: 
total hip arthroplasty; ASA: American Society of Anesthesiologists; Hb: haemoglobin. 
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The post-operative decrease in haemoglobin concentration 
was significantly greater in the PABD+PCS group than 
in the PCS group, irrespectively of whether the patients 
had undergone THA or TKA (P <0.001). Most probably, 
this difference stemmed directly from the autologous 
blood donation, as shown by the two haemoglobin values 
in the PABD+PCS group (Table I). 
Transfusion rates
Overall, the transfusion rate was 9.11% (42 of 
461 patients). Table II reports the transfusion rates 
by procedure type and transfusion strategy. None of 
the patients with an autologous blood unit received 
allogeneic blood transfusion. The transfusion rate was 
higher in the PABD+PCS group than in the PCS group, 
irrespectively of whether the patients had undergone 
THA or TKA. A statistically significant difference was 
observed only in the THA patients and in the overall 
series, probably because of the small number of TKA 
patients who were transfused. An analysis of transfusion 
rates based on the ASA score revealed that the rate 
was higher in the PABD+PCS group than in the PCS 
group across all ASA classes. It was statistically higher 
among ASA class II patients in the THA group who had 
predeposited autologous blood as compared to those who 
did not. Despite the higher transfusion rates in PABD 
patients, a total of 157 (86.3%) autologous blood units 
were wasted. 
Haemoglobin basal concentration as an index of 
transfusion requirements
Basal haemoglobin values were compared in 
patients with and without PABD to identify differences, 
if any, between transfused and non-transfused 
patients. A ROC analysis was applied to assess the 
predictive potential of the basal haemoglobin level on 
transfusion requirements (Figure 1). For both the PCS 
and the PABD+PCS groups, the basal haemoglobin 
concentration emerged as a good predictor of the need 
for blood transfusion: the area under the curve (AUC) 
was significantly larger than a non-discriminating test 
(identity line) (P <0.01 in the PCS group and P <0.05 
in the PABD+PCS group).
The sensitivity threshold was 92% at a basal 
haemoglobin concentration of 15.85 g/dL in the 
PABD+PCS group while a slightly higher threshold 
of 94.12% was observed at a basal haemoglobin 
concentration of 14.65 g/dL in the PCS group. At these 
haemoglobin levels the specificity was lower in the 
PABD+PCS group than in the PCS group (11.46% vs 
31.68%). This indicates that setting a threshold trigger 
of 15.85 g/dL, above which PABD would not be useful, 
would save only 11% of wasted PABD units, with 8% 
of patients at risk for non-reserved blood needs. In 
contrast, setting the threshold trigger at 14.65 g/dL, 
above which ordering allogeneic blood units would 
be unnecessary, would save about 30% of non-used 
reserved blood, with only 6% of patients needing 
non-reserved blood units.
Table II - Transfusion rates as percentages and total numbers according to ASA class, transfusion strategy and orthopaedic procedure.
Procedure Overall PABD+PCS group PCS group
Overall 9.1 (42) 13.7 (25)** 6.1 (17)**
TKA 6.8 (15) 9.7 (8) 5.0 (7)
THA 11.1 (27) 17 (17)* 7.0 (10)*
ASA Class I
Overall 11.9 (10) 13.1 (8) 8.7 (2)
TKA 11.5 (3) 11.1 (2) 12.5 (1)
THA 12.1 (7) 14.0 (6) 6.7 (1)
ASA Class II
Overall 8.5 (32) 14.0 (17) 5.8 (15)
TKA 6.2 (12) 9.4 (6) 4.7 (6)
THA 10.8 (20) 19.3 (11)* 7.0 (9)*
Legend *p <0.05; **p <0.01.
PABD: pre-operative blood donation; PCS: post-operative cell salvage; TKA: total knee arthroplasty; THA: total hip arthroplasty; ASA: American 
Society of Anesthesiologists. 
Figure 1 - ROC curve of basal haemoglobin concentration.
ROC curves with the basal haemoglobin concentrations 
of transfused and non-transfused patients was built for the 
PABD+PCS and PCS groups. For both transfusion strategies, 
basal haemoglobin concentration was predictive of transfusion, 
as it differed significantly from the non-discriminating test 
(straight line: identity). PABD+PCS: P <0.05; PCS: P <0.01.
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Net decrease in haemoglobin concentration 
Since the basal haemoglobin concentration was 
measured before PABD, the difference between the 
baseline and the haemoglobin concentrations at discharge 
could give a reasonable estimate of  peri-operative blood 
loss and recovery after transfusion. Table III reports 
the difference (haemoglobin concentration at discharge 
minus basal haemoglobin concentration) for each 
category of patients. The patients in the PABD group had 
a greater net decrease in haemoglobin concentration than 
that of patients not in the PABD group, the non-transfused 
patients and, slightly, also those who received blood 
transfusions. The differences between the non-transfused 
patients were all statistically significant, while, probably 
because of the small number of transfused patients, a 
statistical significance in this subgroup was found only 
in the THA patients. 
Post-operative cell salvage
PCS blood was re-infused in 307/461 patients 
(66.6%); their shed blood volume was >300 mL and the 
difference between the blood loss in the re-infused and 
the non-re-infused patients was statistically significant 
for each group (P <0.001). Despite this obvious 
difference, the indicators of recovery of physiological 
status, such as transfusion rates and post-operative 
haemoglobin concentrations (measured after PCS 
reinfusion, if administered) and those observed at 
discharge were all similar between the patients who 
received reinfusion and those who did not. The only 
difference was the length of stay in hospital, which was 
slightly longer, even if not clinically relevant, in the 
re-infused patients (Table IV). These results remained 
unchanged when the patients were stratified according 
to type of procedure.
Table III - Net decrease in haemoglobin concentration 
according to transfusion strategy and orthopaedic 
procedure in transfused vs non-transfused 
patients between discharge and baseline.
Transfused patients PABD+PCS PCS
Overall (g/dL) –4.9±1.2 –4.3±1.2
TKA (g/dL) –4.3±1.1 –4.4±1.2
THA (g/dL) –5.2±1.1* –4.2±1.7 *
Non-transfused patients
Overall (g/dL) –4.2±1.1*** –3.6±1.2***
TKA (g/dL) –4.3±1.2*** –3.7±1.2***
THA (g/dL) –4.2±1.1*** –3.6±1.2***
Legend ***p <0.001; *p <0.05.
PABD: pre-operative blood donation; PCS: post-operative 
cell salvage; TKA: total knee arthroplasty; THA: total hip 
arthroplasty.
Table IV - Physiological parameters after surgery in re-infused and not re-infused PCS patients, for the overall series and 
according to transfusion strategy.
Overall Re-infused Not re-infused
N. of patients %) 307 (66.6) 154 (33.4)
Shed blood in drainage (mL) 560±200*** 296±112***
Difference between post-operative and basal Hb concentrations (g/dL) –2.4±1.1 –2.5±1.0
Difference between at discharge and basal Hb concentrations (g/dL) –3.9±1.3 –3.9±1.1
N. of days in hospital 4.0±2.6* 3.5±2.1*
Transfusion rate (%) 9.1 9.0
PABD+PCS
N. of patients (%) 117 (64.3) 65 (35.7)
Shed blood in drainage (mL) 561±197*** 289±111***
Difference between post-operative and basal Hb concentrations (g/dL) –3.0±0.9 –3.1±0.9
Difference between at discharge and basal Hb concentrations (g/dL) –4.3±1.1 –4.3±1.2
N. of days in hospital 4.4±3.4 3.6±1.3
Transfusion rate (%) 14.5% 12.3%
PCS
N. of patients (%) 190 (68.1) 89 (31.9)
Shed blood in drainage (mL) 559±202*** 300±113***
Difference between post-operative and basal Hb concentrations (g/dL) –2.0±0.9 –2.0±0.9
Difference between at discharge and basal Hb concentrations (g/dL) –3.7±1.3 –3.6±1.0
No. of days in hospital 3.8±1.9 3.5±2.5
Transfusion rate (%) 5.8% 6.7%
Legend *p <0.05; ***p <0.001
PABD: pre-operative blood donation; PCS: post-operative cell salvage; Hb: haemoglobin.
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Discussion
Due to its retrospective nature, this study has 
several limitations, including the non-randomised 
design, which did not allow for complete control of 
peri-operative variables such as demographics and 
co-morbidities. Moreover, the procedures carried out 
at our Institute, like the PABD programme which 
involves a single blood donation within 1 month before 
surgery, minimally invasive surgery and hypotensive 
anaesthesia, may limit the generalisability of our 
findings to other settings. Despite these limitations, 
our analysis focused on a large number of cases, 
and the variables were minimised to the extent that 
the patients were all treated by a single orthopaedic 
surgeon and a single anaesthesiologist, thus ensuring 
standardised procedures. Moreover, we were able to 
pinpoint transfusion needs in TJA, whereas the current 
literature on blood management in orthopaedics often 
reports contradictory statements without definitive 
conclusions.
None of the patients in the PABD group required 
allogeneic blood transfusion. Due to marked variability 
in techniques, patients' characteristics and transfusion 
strategies, reported transfusion rates differ widely. The 
overall transfusion rate for TJA at our institute between 
January 2010 and June 2011 was 14.7% (all patients, 
n =600), which is comparable to other recent data16-19. 
This rate is, however, considerably lower than that found 
in older studies10,20,21, suggesting that modern surgical 
techniques, such as minimally invasive surgery5,6, are 
effective in reducing blood requirements in TJA. 
None of the algorithms to predict blood loss and 
transfusion needs in TJA proposed so far7,22-26 appear to 
be widely effective16,27. According to our data, the simple 
measurement of basal haemoglobin concentration could 
be sufficient to effectively reduce non-used autologous 
and allogeneic blood units, as already suggested 
elsewhere28,29. Specifically, if autologous blood were 
requested only for patients with a baseline haemoglobin 
concentration below a threshold of 14.65 g/dL, a total 
of 83 requested and non-used allogeneic blood units 
(31.7%) would have been saved, while only one patient 
(0.4%, THA) would have needed an emergency request 
for blood. The threshold calculated for the PABD 
patients was higher (15.85 g/dL). Use of this threshold 
trigger in blood transfusion decision-making would 
have saved only 9.5% of discarded units (15 out of 
157), while two patients (1.1%) would have needed an 
emergency request for blood units. Furthermore, there 
appears no reason to adopt different threshold triggers 
for PABD+PCS and PCS only patients, as their starting 
conditions are identical.
Accordingly, the higher threshold value calculated for 
the PABD+PCS patients is consistent with the observation 
that PABD is a risk factor that increases the transfusion 
probability in younger and healthier (according to ASA 
score, basal haemoglobin concentration and presence 
of co-morbidities) patients. Moreover, patients who 
had predeposited blood had a greater net decrease 
in haemoglobin concentration at discharge and after 
surgery, even though donated autologous blood had 
been transfused. These observations, taken together, 
demonstrate that PABD has a negative effect on patients, 
and are consistent with the decline in participation in 
PABD protrammes in recent years9,30-34.
The basal haemoglobin concentration was, however, 
characterised by a low specificity (30%) albeit still 
sufficient for informing a policy for down-sizing blood 
transfusion procedures before surgery: the percentage of 
patients at risk of needing blood during and after surgery 
is acceptable in a setting of major surgery and TJA.
Moreover, no clear differences were observed 
between the patients re-infused and not re-infused with 
PCS, in terms of decrease in haemoglobin concentration 
and transfusion rate, while the re-infused patients had 
a much greater blood loss than the non-re-infused 
ones; therefore, PCS blood administration seems 
to be effective in preventing further complications. 
Previous studies demonstrated a decrease in transfusion 
rates after PCS blood reinfusion35, while we did not 
observed any difference: this disagreement could be 
due to the lack of a control group in our study, in 
which the patients who lost more than 300 mL were 
not re-infused. Unlike other studies, however, the shed 
blood volume was accurately evaluated and measured 
in this series. For example, we observed that the 
drainage volume was higher in the TKA group, while 
the decrease in haemoglobin concentration was greater 
in the THA group. This difference may be explained 
by the greater efficacy of drainage, and subsequently 
PCS reinfusion, in TKA as compared to THA, in which 
blood collection in drainage is more difficult because 
of tissue characteristics. 
In conclusion, the current PABD programme 
at our institute may be regarded as useless if not 
harmful. Pharmacological support or prolonging the 
time between donation and surgery could enhance its 
effectiveness, but this might drive up costs without 
providing benefits for patients. In contrast, PCS 
reinfusion seems to be useful in reducing the impact 
of surgery on a patient's physiological status. Finally, 
baseline haemoglobin concentration could be a useful 
indicator of transfusion requirements; nonetheless, 
the transfusion thresholds will need to be defined 
for the facility and the blood transfusion team, and 
regularly audited.
The Authors declare no conflicts of interest.
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